穴位按压治疗呼吸道过敏性疾病:随机对照试验系统综述
该系统综述检索13个中英文数据库至2017年7月,纳入4项随机对照试验(2项过敏性鼻炎、2项哮喘)。因试验少、设计异质性大且偏倚风险高/不明确,无法得出穴位按压对过敏性鼻炎和哮喘疗效的可靠结论;穴位按压似对症状缓解安全,但需更大样本严格试验确认。
要点
- 穴位按压对比1%麻黄素滴鼻加温热疗法,对过敏性鼻炎鼻部症状缓解更优。
- 穴位按压加沙丁胺醇较单用沙丁胺醇,显著改善哮喘患者肺功能(仅1项研究)。
- 另2项研究未发现组间任何结局指标有显著差异。
核心结论
- 因纳入试验少、设计异质性显著且偏倚风险高/不明确,本综述无法就穴位按压对过敏性鼻炎和哮喘的疗效得出可靠结论。
- 穴位按压似对过敏性鼻炎和哮喘的症状缓解安全,但需更大规模研究才能稳健确认其安全性。
研究设计与样本
- 系统综述检索13个英文和中文电子数据库,截至2017年7月。
- 初检186篇文献,最终纳入4项随机对照试验:2项过敏性鼻炎、2项哮喘。
- 两名作者独立提取数据并评估偏倚风险,使用Review Manager V.5.3分析。
- 所有纳入研究均存在高偏倚风险或不明确偏倚风险。
主要发现
- 与1%麻黄素滴鼻加温热疗法相比,穴位按压对过敏性鼻炎鼻部症状缓解效果更优。
- 一项研究显示,以西药或中药为共同干预时,穴位按压加沙丁胺醇较单用沙丁胺醇显著改善哮喘患者肺功能。
- 其余两项研究未发现两组间任何结局指标有显著差异。
关键数值与推荐
- 与1%麻黄素滴鼻加温热疗法相比,穴位按压对过敏性鼻炎鼻部症状缓解效果更优。
- 穴位按压加沙丁胺醇较单用沙丁胺醇显著改善哮喘患者肺功能(仅1项研究)。
- 另2项研究未发现组间任何结局指标有显著差异。
- 所有纳入研究均存在高偏倚风险或不明确偏倚风险。
临床怎么用
- 现有证据不足以推荐穴位按压作为过敏性鼻炎或哮喘的常规治疗。
- 在共同干预基础上,穴位按压可能作为症状缓解的辅助手段,但需个体化评估。
- 临床应用时应关注安全性,并告知患者证据质量低且异质性大。
局限性
- 纳入试验数量少(仅4项),样本量有限。
- 研究设计异质性显著,偏倚风险高或不明确。
- 无法进行可靠Meta分析,结论可靠性受限。
- 安全性结论需更大规模研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects and safety of acupressure for the management of respiratory allergic diseases by systematically reviewing randomised controlled trials (RCTs). METHODS: A total of 13 electronic English and Chinese databases were searched until July 2017. Two authors extracted data and evaluated risk of bias independently. Review Manager V.5.3 was employed for data analysis. RESULTS: The literature search identified 186 papers, of which only four of met the inclusion criteria: two for allergic rhinitis (AR) and two for asthma. High and unclear risk of bias existed across all the included studies. The findings demonstrated that acupressure greater effects on the relief of nasal symptoms of AR compared with 1% ephedrine nasal drop plus thermal therapy. With either Western medicine or Chinese herbal medicine as a cointervention, one study indicated that acupressure plus salbutamol was led to a significantly greater improvement of pulmonary function for patients with asthma compared with salbutamol only. However, the remaining two studies indentified no significant differences in any outcome measures between the two groups. CONCLUSIONS: No reliable conclusions regarding the effects of acupressure on AR and asthma could be drawn by this review due to the small number of available trials with significant heterogeneity of study design and high/unclear risk of bias. Further, more rigorously designed RCTs are needed. Acupressure seems safe for symptomatic relief of AR and asthma, although larger studies are required to be able to robustly confirm its safety. TRIAL REGISTRATION NUMBER: ACTRN12617001106325; Pre-results.
引用
- Liang Y, Lenon GB, Yang AWH, et al. Acupressure for respiratory allergic diseases: a systematic review of randomised controlled trials. Acupunct Med. 2017. PMID: 29113981. doi:10.1136/acupmed-2016-011354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。